Skip to main content
Fig. 3 | Cancer Nanotechnology

Fig. 3

From: HepG2 exosomes coated luteolin nanoparticles remodeling hepatic stellate cells and combination with sorafenib for the treatment of hepatocellular carcinoma

Fig. 3

LX2 cells uptake of DiD-NPs and Exo-DiD-NPs after incubation for 2 h. A Inverted fluorescence microscope images of LX2 cells treated with the DiD-NPs and Exo-DiD-NPs, respectively. B Intensity of internalized DiD labeled nanoparticles in terms of DiD fluorescence intensity normalized to DAPI quantified by ImageJ (n = 4), **P < 0.01

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us